142 related articles for article (PubMed ID: 10520506)
21. Structural analogs of huperzine A improve survival in guinea pigs exposed to soman.
Gunosewoyo H; Tipparaju SK; Pieroni M; Wang Y; Doctor BP; Nambiar MP; Kozikowski AP
Bioorg Med Chem Lett; 2013 Mar; 23(5):1544-7. PubMed ID: 23395652
[TBL] [Abstract][Full Text] [Related]
22. [Advances on study of organophosphate poisoning prevented by Huperzine A].
Liu L; Sun JX
Wei Sheng Yan Jiu; 2005 Mar; 34(2):224-6. PubMed ID: 15952670
[TBL] [Abstract][Full Text] [Related]
23. Green tea polyphenol (-)-epigallocatechin-3-gallate enhances the inhibitory effect of huperzine A on acetylcholinesterase by increasing the affinity with serum albumin.
Zhang L; Cao H; Wen J; Xu M
Nutr Neurosci; 2009 Aug; 12(4):142-8. PubMed ID: 19622237
[TBL] [Abstract][Full Text] [Related]
24. Potential therapeutic targets of huperzine A for Alzheimer's disease and vascular dementia.
Zhang HY; Zheng CY; Yan H; Wang ZF; Tang LL; Gao X; Tang XC
Chem Biol Interact; 2008 Sep; 175(1-3):396-402. PubMed ID: 18565502
[TBL] [Abstract][Full Text] [Related]
25. Comparative effects of huperzine A, donepezil and rivastigmine on cortical acetylcholine level and acetylcholinesterase activity in rats.
Liang YQ; Tang XC
Neurosci Lett; 2004 May; 361(1-3):56-9. PubMed ID: 15135892
[TBL] [Abstract][Full Text] [Related]
26. The psychopharmacology of huperzine A: an alkaloid with cognitive enhancing and neuroprotective properties of interest in the treatment of Alzheimer's disease.
Zangara A
Pharmacol Biochem Behav; 2003 Jun; 75(3):675-86. PubMed ID: 12895686
[TBL] [Abstract][Full Text] [Related]
27. Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission.
Duysen EG; Li B; Darvesh S; Lockridge O
Toxicology; 2007 Apr; 233(1-3):60-9. PubMed ID: 17194517
[TBL] [Abstract][Full Text] [Related]
28. [Pretreatment of organophosphate poisoning: potential interests of huperzine A].
Lallement G
Ann Pharm Fr; 2000 Jan; 58(1):13-7. PubMed ID: 10669806
[TBL] [Abstract][Full Text] [Related]
29. Assessment of the neuroprotective effects of the acetylcholinesterase inhibitor huperzine A in an experimental spinal cord trauma model.
Antar V; Baran O; Yuceli S; Erdogan H; Altintas O; Baran GE; Tasdemiroglu E
J Neurosurg Sci; 2018 Apr; 62(2):128-139. PubMed ID: 26472141
[TBL] [Abstract][Full Text] [Related]
30. Acetylcholinesterase complexed with bivalent ligands related to huperzine a: experimental evidence for species-dependent protein-ligand complementarity.
Wong DM; Greenblatt HM; Dvir H; Carlier PR; Han YF; Pang YP; Silman I; Sussman JL
J Am Chem Soc; 2003 Jan; 125(2):363-73. PubMed ID: 12517147
[TBL] [Abstract][Full Text] [Related]
31. Comparative studies of huperzine A, donepezil, and rivastigmine on brain acetylcholine, dopamine, norepinephrine, and 5-hydroxytryptamine levels in freely-moving rats.
Liang YQ; Tang XC
Acta Pharmacol Sin; 2006 Sep; 27(9):1127-36. PubMed ID: 16923332
[TBL] [Abstract][Full Text] [Related]
32. The effects of huperzine A and IDRA 21 on visual recognition memory in young macaques.
Malkova L; Kozikowski AP; Gale K
Neuropharmacology; 2011 Jun; 60(7-8):1262-8. PubMed ID: 21185313
[TBL] [Abstract][Full Text] [Related]
33. Huperzine A from Huperzia species--an ethnopharmacolgical review.
Ma X; Tan C; Zhu D; Gang DR; Xiao P
J Ethnopharmacol; 2007 Aug; 113(1):15-34. PubMed ID: 17644292
[TBL] [Abstract][Full Text] [Related]
34. Huperzine A as a neuroprotective and antiepileptic drug: a review of preclinical research.
Damar U; Gersner R; Johnstone JT; Schachter S; Rotenberg A
Expert Rev Neurother; 2016 Jun; 16(6):671-80. PubMed ID: 27086593
[TBL] [Abstract][Full Text] [Related]
35. Huperzine A, a nootropic agent, inhibits fast transient potassium current in rat dissociated hippocampal neurons.
Li Y; Hu GY
Neurosci Lett; 2002 May; 324(1):25-8. PubMed ID: 11983286
[TBL] [Abstract][Full Text] [Related]
36. Clinical use of an herbal-derived compound (Huperzine A) to treat putative complex partial seizures in a dog.
Schneider BM; Dodman NH; Faissler D; Ogata N
Epilepsy Behav; 2009 Aug; 15(4):529-34. PubMed ID: 19616481
[TBL] [Abstract][Full Text] [Related]
37. Anti-acetylcholinesterase activities of traditional Chinese medicine for treating Alzheimer's disease.
Lin HQ; Ho MT; Lau LS; Wong KK; Shaw PC; Wan DC
Chem Biol Interact; 2008 Sep; 175(1-3):352-4. PubMed ID: 18573242
[TBL] [Abstract][Full Text] [Related]
38. Effects of huperzine A on secretion of nerve growth factor in cultured rat cortical astrocytes and neurite outgrowth in rat PC12 cells.
Tang LL; Wang R; Tang XC
Acta Pharmacol Sin; 2005 Jun; 26(6):673-8. PubMed ID: 15916732
[TBL] [Abstract][Full Text] [Related]
39. Natural and synthetic Huperzine A: effect on cholinergic function in vitro and in vivo.
Hanin I; Tang XC; Kindel GL; Kozikowski AP
Ann N Y Acad Sci; 1993 Sep; 695():304-6. PubMed ID: 8239300
[TBL] [Abstract][Full Text] [Related]
40. [Facilitation of cholinergic transmission by huperzine A in toad paravertebral ganglia in vitro].
Zhang GB; Wang MY; Zheng JQ; Tang XC
Zhongguo Yao Li Xue Bao; 1994 Mar; 15(2):158-61. PubMed ID: 8010112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]